ClientTell Joins Greenway Online Marketplace with ReminderManager™ Certified API Solution

Published on:

VALDOSTA, Ga., May 21, 2013 -- ClientTell, an enterprise-class notifications company, today announced that its ReminderManager patient communication solution has joined the Greenway Medical Technologies Online Marketplace as a certified API solution for users of Greenway's PrimeSUITE platform.

As a Marketplace certified API solution, ReminderManager has been proven to deliver value-added interoperability with the Greenway PrimeSUITE electronic health record (EHR) and practice management solution, supporting providers in delivering high-quality, cost-effective care.

Hospitals, health systems and physician practices benefit from the comprehensive communication center offered by ClientTell. Patient messaging technology provided by ClientTell is proven to increase efficiency and reduce no-shows while improving overall staff productivity and morale. ClientTell's messaging solutions are instantly affordable, and the ROI impact is immediate for any healthcare organization. The ReminderManager certification will enable Greenway customers to experience an advanced level of integration for greater efficiencies.

"We are excited about the ReminderManager certification and our presence in the Greenway Marketplace. We remain committed to our customers through innovation and improved interoperability with Greenway PrimeSUITE," said Patrick Sullivan, ClientTell CEO. "This phase of certification also prepares us for future product enhancements and improved communication tools for practices utilizing the PrimeSUITE platform."

"The Greenway Marketplace API Certification program was developed to foster collaboration and speed and simplify the adoption of innovation, helping our customers easily evaluate and select integrated products that add value to their PrimeSUITE solution," said Jared Lisenby, Greenway Vice President of Business Development. "We're pleased to partner with ClientTell for mutual promotion of ReminderManager through the Marketplace to our customers who seek the interoperability and functionality that's essential to successfully navigating the future of healthcare."

About ClientTell

ClientTell, Inc. is a leading provider of cloud-based notifications and patient messaging solutions. Utilizing a web-native communication platform, the hosted offering provides unrivaled performance and reliability delivering notifications through phone, email, text and smartphone applications. ClientTell has earned its referral-based success through quality service and outstanding customer support. Over 45,000 providers rely on ClientTell for delivering appointment reminders and related notifications while also providing the receipt and delivery of lab results. ClientTell pioneered the hosted model of patient messaging, an approach that has been widely adopted by the industry. For more information, please visit www.clienttell.net or call (877) 244-9178.

Related Content

Christmas ransomware exposed over 300K patient records to dark web
Private equity-backed cardiology group puts cloud-based technology in hands of its cardiologists
AI helps cardiologists deliver personalized healthcare—but there is still plenty of work to do
Indiana hospitals reduce nuisance alerts by 77% with medication decision support software
Leveraging machine learning to rapidly create clinical AI algorithms
How medication reconciliation data consolidation in the EHR enables better patient care

Around the web

Cardiovascular Business
FDA says years-long tirzepatide shortage is resolved, will give limited leeway to compounders

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

AI in Healthcare
From Capitol Hill to a hospital near you? 5 federal recommendations for healthcare AI policy

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Cardiovascular Business
Merck spends up to $2B to license new weight loss drug with potential heart benefits

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.